Healius Limited (ASX:HLS)
Australia · Delayed Price · Currency is AUD 1.000
0.00 (0.00%)
At close: Nov 27, 2025
Healius Market Cap
Healius has a market cap or net worth of 726.13 million as of November 26, 2025. Its market cap has decreased by -37.11% in one year.
Market Cap
726.13M
Enterprise Value
1.58B
Revenue
1.34B
Ranking
n/a
PE Ratio
n/a
Stock Price
1.00
Market Cap Chart
Since August 29, 2000, Healius's market cap has increased from 478.57M to 726.13M, an increase of 51.73%. That is a compound annual growth rate of 1.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 726.13M | -27.01% |
| Dec 31, 2024 | 994.80M | -16.20% |
| Dec 29, 2023 | 1.19B | -32.22% |
| Dec 30, 2022 | 1.75B | -43.13% |
| Dec 31, 2021 | 3.08B | 32.57% |
| Dec 31, 2020 | 2.32B | 35.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 88.35B |
| Pro Medicus | 27.17B |
| Cochlear | 18.05B |
| Sonic Healthcare | 11.46B |
| Ramsay Health Care | 8.27B |
| Ansell | 5.23B |
| Telix Pharmaceuticals | 5.03B |
| Mesoblast | 2.99B |